Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content. This indicates an access issue that prevents viewing the study details.
    Difference
    17%
    Check dated 2026-09-19T22:25:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page's related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics', removing those topics from the study's contextual references.
    Difference
    0.2%
    Check dated 2026-09-12T20:23:54.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes links to related topics for Multiple Myeloma and MedlinePlus Genetics, expanding access to contextual information about the disease on the study record.
    Difference
    0.2%
    Check dated 2026-09-05T17:31:04.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new page revision label Revision: v3.6.6 was added, indicating an update to the page metadata. The older revision label Revision: v3.6.5 and several topic tags (Multiple myeloma, related topics:, MedlinePlus Genetics) were removed, reflecting a cleanup of non-core content rather than changes to study details.
    Difference
    0.2%
    Check dated 2026-08-29T13:40:24.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now includes a 'Multiple myeloma' related topics section with a link to MedlinePlus Genetics, expanding cross-reference resources for readers.
    Difference
    0.2%
    Check dated 2026-08-15T03:57:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, representing a minor version bump. This update aligns with backend or template changes rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-08-08T01:00:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.